Healthcare >> CEO Interviews >> October 14, 2002
ELIZABETH A. CORSI, President, Chief Executive Officer and Director of
EXIMIAS Pharmaceutical Corporation, has spent over 17 years in
multinational pharmaceutical companies. Prior to joining EXIMIAS, she
was Senior Vice President for Dupont-Merck Pharmaceuticals, where she
had P&L responsibility for the US pharmaceutical business. From 1991 to
1997, Dr. Corsi held various senior management positions with Rhone-
Poulenc Rorer including Vice President, Planning and Business
Development, Vice President, General Manager and Vice President,
Division Manager. Dr. Corsi also held the position at Schering Plough
International of Senior Director responsible for the Oncology and Anti-
infectives Business Unit. She began her pharmaceutical industry career
at Lederle Laboratories, where she held a series of more responsible
positions including Associate Director, Professional Affairs, Product
Manager, Group Product Director, Director, Product Management and
Director Business Development. Dr. Corsi is a Registered Pharmacist and
earned a BS in Pharmacy from the University of Pittsburgh, an MBA from
Pace University and a Doctor of Pharmacy degree from the Philadelphia
School of Pharmacy and Science. She is a Distinguished Alumna of The
University of Pittsburgh and serves as a Trustee for The University of
the Sciences in Philadelphia. Profile
what you do?
Dr. Corsi: EXIMIAS is a specialty pharmaceutical company that acquires,
develops and commercializes oncology
